Levilex 750 Tablet contains Levetiracetam 750 mg, an antiepileptic medication indicated for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in adults and pediatric patients. Levetiracetam is believed to exert its anticonvulsant effects by binding to the synaptic vesicle protein SV2A, modulating neurotransmitter release and thereby stabilizing neuronal activity. Levilex 750 is typically prescribed as adjunctive therapy for patients who have not achieved adequate seizure control with other antiepileptic drugs. The tablet should be administered orally, with or without food, as directed by a healthcare professional. Dosage adjustments may be required based on renal function, age, and clinical response. Common adverse effects include somnolence, dizziness, fatigue, and irritability, although it is generally well tolerated. Patients should be monitored for behavioral changes, mood alterations, or signs of hypersensitivity. Levilex 750 should not be abruptly discontinued to avoid the risk of increased seizure frequency. Caution is advised in patients with renal impairment, and dose modification may be necessary. This medication should be used under strict medical supervision, with regular follow-up to assess efficacy and safety. It is contraindicated in patients with known hypersensitivity to Levetiracetam or any of its excipients.